Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2007
11/08/2007WO2007126950A1 Parenteral low dose type 1 interferons for bladder cancer
11/08/2007WO2007126857A1 Diamidine inhibitors of tdp1
11/08/2007WO2007126849A1 Cyclic hexadepsipeptides, processes for their production and their use as pharmaceuticals
11/08/2007WO2007126455A2 Method for using boc/cdo to modulate hedgehog signaling
11/08/2007WO2007126439A2 Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r
11/08/2007WO2007126150A1 Novel composition for treating cancer
11/08/2007WO2007126128A1 Dihydropyrazolopyrimidinone derivative
11/08/2007WO2007126126A1 Novel aminopyridine derivative having aurora-a-selective inhibitory activity
11/08/2007WO2007126122A1 Dihydropyrazolopyrimidinone derivatives
11/08/2007WO2007125823A1 Composition comprising polysaccharide having immunomodulating function as main ingredient
11/08/2007WO2007125621A1 Novel use of gene whose expression is increased in hyperplastic pancreatic islet
11/08/2007WO2007125619A1 Novel compound having gpr54 agonistic activity
11/08/2007WO2007125330A1 Imidazo[4, 5-b]pyridin-2-one and oxazolo[4, 5-b]pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds
11/08/2007WO2007125325A1 Pharmaceutical compounds
11/08/2007WO2007125320A1 Pharmaceutical compounds
11/08/2007WO2007125310A2 Pharmaceutical combinations of pk inhibitors and other active agents
11/08/2007WO2007125197A1 Novel imidazole derivatives, preparation and user thereof as medicine
11/08/2007WO2007125196A1 Type 1, 4-naphtoquinone compounds, compositions comprising them and use of these compounds as anti-cancer agents
11/08/2007WO2007124849A2 Inhibitors of the task-1 and task-3 ion channel
11/08/2007WO2007124734A2 Compounds a-r-x for the manufacture of pharmaceutical preparations
11/08/2007WO2007124668A1 Pharmaceutical composition comprising high concentrate of polydatin
11/08/2007WO2007124625A1 Limax polysaccharides, the production process and the use of the same
11/08/2007WO2007124589A1 Methods for treating or preventing neoplasias
11/08/2007WO2007109609A8 Method for inhibiting angiogenesis
11/08/2007WO2007103427A3 Medical use of bilirubin and its structural analogues
11/08/2007WO2007100385A3 Macrocyclic depsipeptide antibody-drug conjugates and methods
11/08/2007WO2007099348A3 Cathepsin propeptide and uses thereof
11/08/2007WO2007087395A3 UNSATURATED mTOR INHIBITORS
11/08/2007WO2007084868A3 Treatment of disorders by activation of the unfolded protein response
11/08/2007WO2007079171A3 Treatment for hodgkin's lymphoma
11/08/2007WO2007076087A3 3-aryl-substituted quinazolones, and uses thereof
11/08/2007WO2007072221A3 Surface marker-directed cancer therapeutics
11/08/2007WO2007070568A3 Demethylpenclomedine analogs and their use as anticancer agents
11/08/2007WO2007055926A8 Negative immunomodulation of immune responses by nkg2d-positive cd4+ cells
11/08/2007WO2007038868A3 Novel enediyne compound and uses thereof
11/08/2007WO2007025388A3 Anti-apoptotic protein antibodies
11/08/2007WO2002022145A3 Components of canola for the treatment of cancer
11/08/2007US20070259969 Using CD44 expression profile as diagnostic indicator of cell proliferative disorders
11/08/2007US20070259966 Coadministration of Radiation, Efaproxiral Sodium, and Supplemental Oxygen for the Treatment of Cancer
11/08/2007US20070259951 mitotic kinesins like KSP inhibitors; for treating cellular proliferative diseases; N-[(3-methyl-4'-trifluoromethyl)-4-biphenylyl]methanesulfonamide
11/08/2007US20070259944 Amides such as 5-(3-Nitrophenyl)-1,3-dihydro-indol-2-one, used as antiprogesterones, contraceptives, for hormone replacement therapy during menopause and as anticarcinogenic agents
11/08/2007US20070259918 2-Hydroxymethyl-3,4,5-Trihydroxy-1-(4-Pentyloxybenzyl) Piperidine as Glucosylceramide Synthase (Gcs) Inhibitor
11/08/2007US20070259911 N-(6-tert.-Butyloxycarbonyl-3-cyano-4,5,6,7-tetrahydro-thieno[2,3-c]pyridin-2-yl)-benzamide; antiproliferative agent; anticarcinogenic agent
11/08/2007US20070259905 silyl camptothecin derivatives for cancer and/or leukemia; cytotoxic; DNA-topoisomerase I inhibitors; antitumor agents; 7-trimethylsilyl-10-acetoxy camptothecin, 7-trimethylsilyl-11-fluoro camptothecin
11/08/2007US20070259904 Bi-aryl meta-pyrimidine inhibitors of kinases
11/08/2007US20070259902 Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer
11/08/2007US20070259901 Pharmaceutical compositions and use thereof
11/08/2007US20070259892 e.g. 1,3-benzothiazol-2-yl (2-chloral -4-pyrimidinyl)acetonitrile; Jun N -terminal kinase inhibitor; anticarcinogenic agent; neuronal disorders, autoimmune diseases, cardiovascular disordres
11/08/2007US20070259891 Heterocycle-Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase Inhibitors
11/08/2007US20070259889 Protein Binding Compounds
11/08/2007US20070259887 Inhibitors of polyq-aggregation
11/08/2007US20070259886 Dihydroxyphenyl isoindolylmethanones
11/08/2007US20070259884 4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
11/08/2007US20070259881 Substituted Imidazo Ring Systems and Methods
11/08/2007US20070259871 Hydroxybenzamide Derivatives And Their Use As Inhibitors Of HSP90
11/08/2007US20070259870 Novel Pyridazinone Derivatives
11/08/2007US20070259869 inhibitors of Aurora protein kinases; antiproliferative agents; melanoma, myeloma, leukemia, lymphoma, neuroblastoma, and cancer; N-(4-(4-(3-methyl-1H-pyrazol-5-ylamino)-6-chloropyrimidin-2-ylthio)phenyl)cyclopentanecarboxamide
11/08/2007US20070259858 Novel bis-pyrrolo[2,1-c][1,4]benzodiazepine-anthraquinone conjugates and a process for the preparation thereof
11/08/2007US20070259849 Azine-Carboxamides as Anti-Cancer Agents
11/08/2007US20070259838 17,20(Z)-Dehydro Vitamin D Analogs and Their Uses
11/08/2007US20070259829 Tolfenamic acid, diclofenac sodium, and diflunisal; non-steroidal anti-inflammatory drugs inhibited cancer cell growth, angiogenesis, metastasis of cancer cells by inducing degradation of Sp transcription factors; decreases expression of vascular endothelial growth factor; reducing toxicity of therapy
11/08/2007US20070259828 poly(N-(2-hydroxypropyl)methacrylamide) (PHPMA) and poly(N-[3-(dimethylamino)propyl]methacrylamide) (PDMAPMA); protecting siRNA, shRNA or miRNA from enzymatic degradation by complexing the siRNA, shRNA or miRNA with a hydrophilic/cationic block copolymer
11/08/2007US20070259826 Chimeric (Double) Decoy
11/08/2007US20070259817 CLK-peptide and SLK-peptide
11/08/2007US20070259816 Expression vector comprising nucleotide sequences coding homeobox gene for use in identifying modulators for treatment and prevention of nervous system and seizure disorders
11/08/2007US20070259815 Albumin fusion proteins
11/08/2007US20070259811 Method of modulating the proliferation of medullary thyroid carcinoma cells
11/08/2007US20070259422 isolated nucleic acid encoding an immunogenic peptide recognized by T lymphocytes; host cell transfected with the recombinant expression vector encoding an immunogenic protein; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
11/08/2007US20070259400 Antibodies
11/08/2007US20070259383 Novel Genes involved in Epidermal differentiation, and uses thereof
11/08/2007US20070259372 Melanoma differentiation associated gene - 5 and promoter and uses thereof
11/08/2007US20070259060 Formulations and Methods for Treating Breast Cancer with Morinda Citrifolia and Methylsulfonymethane
11/08/2007US20070259056 Anti-Tumour Terpene Compounds
11/08/2007US20070259036 Lactic acid polymer and process for producing the same
11/08/2007US20070259006 Shed antigen vaccine with dendritic cells adjuvant
11/08/2007US20070259005 Method of treating cancer
11/08/2007US20070258987 Recombinant Anti-Cd30 Antibodies and Uses Thereof
11/08/2007US20070258985 Human mini-antibody cytotoxic for tumor cells which express the ERB-B2 receptor
11/08/2007US20070258984 Anti-neoplastic composition of 5-FU, leucovorin, irinotecan, oxaliplatin, capecitabine, paclitaxel or doxetaxel; breast cancer, colorectal cancer, rectal cancer, non-small cell lung cancer, non-Hodgkins lymphoma (NHL), renal cell cancer, prostate cancer, liver cancer
11/08/2007US20070258980 Vascular endothelial cell growth factor antagonists and uses thereof
11/08/2007US20070258977 Inhibiting OX-2 (also called CD200) gene expression to treat a tumor that is associated with increased CD200 expression; leukemia; phage display screening for antigens; monoclonal antibodies; fusion proteins; use of OX-2 preventing graft rejection, autoimmune disease, and in inducing tumor cell growth
11/08/2007US20070258974 Diagnostics and Therapeutics for Diseases Associated with Puromycin Sensitive Aminopeptidase Npepps (Npepps)
11/08/2007US20070258972 Combination of a Histone Deacetylase Inhibitor with a Death Receptor Ligand
11/08/2007US20070258944 Multiple cytokine protein complexes
11/08/2007US20070258906 Methods and devices for detection and therapy of atheromatous plaque
11/08/2007US20070258899 Diagnostic and therapeutic agents
11/08/2007DE102006021154A1 Zubereitungen aus Myrte, ihren Inhaltsstoffen und/oder deren Derivaten zur Therapie von Krebserkrankungen Preparations of myrtle, their ingredients and / or derivatives thereof for treatment of cancer
11/08/2007DE102006020307A1 Transgenic mesenchymal stem cells stably expressing tumor necrosis factor-related apoptosis-inducing ligand, e.g. useful for treating tumors
11/08/2007CA2650577A1 Use of 12-imidazolyl-1-dodecanol or its pharmaceutically acceptable salts for producing a pharmaceutical preparation
11/08/2007CA2650572A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
11/08/2007CA2650485A1 Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation
11/08/2007CA2650480A1 Type 1, 4-naphtoquinone compounds, compositions comprising them and use of these compounds as anti-cancer agents
11/08/2007CA2650391A1 Inhibitors of the task-1 and task-3 ion channel
11/08/2007CA2650385A1 Novel imidazole derivatives, preparation and user thereof as medicine
11/08/2007CA2650383A1 Diazeniumdiolated non-steroidal anti-inflammatory drugs, compositions thereof, and related methods
11/08/2007CA2650295A1 Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them
11/08/2007CA2650290A1 Pharmaceutical compounds
11/08/2007CA2650132A1 Further medical uses of antisecretory protein
11/08/2007CA2650119A1 Dihydropyrazolopyrimidinone derivatives
11/08/2007CA2649994A1 Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds
1 ... 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 ... 2211